Tesamorelin Peptide History
Tesamorelin is a synthetic form of growth hormone-releasing hormone (GHRH) that was developed by Theratechnologies, a Canadian biopharmaceutical company. It was first approved by the US Food and Drug Administration (FDA) in 2010 for the treatment of excess visceral fat (belly fat) in HIV-infected individuals with lipodystrophy. The history of tesamorelin peptide dates back to […]
Tesamorelin Peptide History Read More »